STOK CIK: 1623526

Stoke Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
229
FY22:
244
FY23:
215
FY24:
233
FY25:
306
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.65
FY22:
12.0
FY23:
13.0
FY24:
38.8
FY25:
113
Total assets
Change from FY21 to FY25
millions USD
FY21:
239
FY22:
256
FY23:
228
FY24:
272
FY25:
418

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
17.1
FY22:
31.4
FY23:
30.8
FY24:
40.1
FY25:
57.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.95
FY22:
39.8
FY23:
38.0
FY24:
2.48
FY25:
8.10
(positive)
Change from FY21 to FY25
millions USD
FY21:
218
FY22:
185
FY23:
160
FY24:
229
FY25:
352
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
239
FY22:
256
FY23:
228
FY24:
272
FY25:
418

All amounts in millions USD Data source:SEC EDGAR